Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Hematology"
DOI: 10.1007/s12185-021-03078-x
Abstract: Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect… read more here.
Keywords: covid patients; hematology; thromboprophylaxis covid; patients considered ... See more keywords